Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Molecular Cancer Research : MCR|December 29, 2005
Comprehensive profiling of 8p11-12 amplification in breast cancerVéronique Gelsi-Boyer, Béatrice Orsetti, Nathalie Cervera, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.
The EMBO Journal|March 21, 2022
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progressionVictoire Gouirand, Tristan Gicquel, Evan C Lien, et al.
Oncotarget|October 22, 2016
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective studyAnthony Gonçalves, François Bertucci, Arnaud Guille, et al.
The Journal of Clinical Investigation|December 17, 2020
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancerYuchen Guo, Monica Gabola, Rossano Lattanzio, et al.
Science Advances|December 16, 2022
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancerXiaoping Wang, Takashi Semba, Ganiraju C Manyam, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
Genome Medicine|May 19, 2021
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trialFrançois Bertucci, Anthony Gonçalves, Arnaud Guille, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Molecular Cancer Research : MCR|December 29, 2005
Comprehensive profiling of 8p11-12 amplification in breast cancerVéronique Gelsi-Boyer, Béatrice Orsetti, Nathalie Cervera, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.
The EMBO Journal|March 21, 2022
Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progressionVictoire Gouirand, Tristan Gicquel, Evan C Lien, et al.
Oncotarget|October 22, 2016
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective studyAnthony Gonçalves, François Bertucci, Arnaud Guille, et al.
The Journal of Clinical Investigation|December 17, 2020
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancerYuchen Guo, Monica Gabola, Rossano Lattanzio, et al.
Science Advances|December 16, 2022
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancerXiaoping Wang, Takashi Semba, Ganiraju C Manyam, et al.
Molecular Oncology|March 16, 2015
Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced diseaseMaurice P H M Jansen, Leen Sas, Anieta M Sieuwerts, et al.
Genome Medicine|May 19, 2021
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trialFrançois Bertucci, Anthony Gonçalves, Arnaud Guille, et al.
Molecular Cancer Research : MCR|September 3, 2020
Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic CancerKim C Honselmann, Pascal Finetti, David J Birnbaum, et al.
Nature Medicine|April 11, 2017
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stabilityAnne-Pierre Morel, Christophe Ginestier, Roxane M Pommier, et al.
Pageof 18